Cited by 69Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Treatment and Management

Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80

Open access
Kadowaki, S., Okamura, T., Hozawa, A., Kadowaki, T., Kadota, A., Murakami, Y., Nakamura, K., Saitoh, S. +6 more·2008·Diabetologia

Abstract

Aims/hypothesis High fasting blood glucose is one of the well-known risk factors for CHD. However, in certain settings, patients cannot always be expected to fast. For example, community screenings for cardiovascular disease (CVD) risk factors in Japan are performed under non-fasting conditions to achieve high participation rates. Thus, we examined a representative cohort of the Japanese population (n=9,444, follow-up period 17.3 years) to clarify whether high casual blood glucose (CBG) can predict CVD mortality.Methods We defined CBG groups as follows: high CBG >or= 11.1 mmol/l or participants with a history of diabetes mellitus; borderline high, 7.77 <or= CBG<11.1 mmol/l; higher normal, 5.22 <or= CBG<7.77 mmol/l); and lower normal, CBG<5.22 mmol/l. The multivariate-adjusted hazard ratios (HRs) for CHD, CVD and all-cause mortality were calculated.Results The crude CHD mortality rate was 0.84 per 1,000 person-years. Age- and sex-adjusted HRs for CHD mortality were high among participants with CBG levels >or= 7.77 mmol/l, regardless of time since last meal. Multivariate-adjusted HRs (95% CI) of CHD mortality in high and borderline high CBG groups were 2.62 (1.46-4.67) and 2.43 (1.29-4.58), respectively. Similar results were observed for both CVD and all-cause mortality. Even within the normal blood glucose range, each 1 mmol/l increase in CBG was associated with a statistically significant increase in the HR for CVD mortality (1.12, 95% CI 1.02-1.22). Population-attributable fractions of the combined groups of high and borderline high CBG for CHD, CVD and all-cause mortality were 12.0, 4.9 and 3.5%, respectively.Conclusions/interpretation Increases in CBG, even within the normal range, predict CVD mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-007-0915-6

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kadowaki, S., Okamura, T., Hozawa, A., Kadowaki, T., Kadota, A., Murakami, Y., Nakamura, K., Saitoh, S., Nakamura, Y., Hayakawa, T., Kita, Y., Okayama, A., Ueshima, H., & for the NIPPON DATA Research Group
Affiliations
  • Shiga University of Medical Science (JP)
  • National Cerebral and Cardiovascular Center (JP)
  • Sapporo Medical University (JP)
  • Kyoto Women's University (JP)
  • Fukushima Medical University (JP)
  • Japan Anti Tuberculosis Association (JP)
Corresponding author
Kadowaki, S.
Venue
Diabetologia
Published
2008-01-16
Volume
51
Issue
4
Pages
575-582
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1969711013
Cited by
69
References
40
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 3 · 2014: 5 · 2013: 7 · 2012: 5
FWCI
4.34
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
coronary heart disease mortality, cardiovascular mortality, all-cause mortality, cardiovascular risk factors, diabetes mellitus, population attributable fraction, Japanese population
MeSH terms
Adult, Aged, Alcohol Drinking, Blood Glucose, Cardiovascular Diseases, Cause of Death, Cholesterol, Coronary Disease, Heart Diseases, Humans, Hyperglycemia, Hypertension, Japan, Middle Aged, Smoking, Cohort Studies, Proportional Hazards Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review